Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-008084
Filing Date
2025-01-30
Accepted
2025-01-30 08:00:09
Documents
2
Period of Report
2025-01-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0229151-6k_nlsphar.htm 6-K 11282
2 PRESS RELEASE TITLED: "NLS PHARMACEUTICS ANNOUNCES THE SUBMISSION OF THREE RESEA ea022915101ex99-1_nlsphar.htm EX-99.1 11746
  Complete submission text file 0001213900-25-008084.txt   24071
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 25571208
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)